Press release content from Globe Newswire. The AP news staff was not involved in its creation.
MEDIROM Healthcare Technologies Inc. Announces Closing of $12,000,000 Initial Public Offering
MEDIROM Healthcare Technologies Inc.December 31, 2020 GMT
NEW YORK, Dec. 31, 2020 (GLOBE NEWSWIRE) MEDIROM Healthcare Technologies Inc. (NasdaqCM:MRM), a holistic healthcare company from Japan (the “Company”), announced today that it has closed its previously announced initial public offering of 800,000 ADSs at a price to the public of US$15.00 per share. Each ADS represents one share of the Company’s common stock. After underwriting discounts and offering expenses, the Company expects to receive net proceeds of approximately US$7.8 million.
Propanc Biopharma Advances POP1 Joint Research and Drug Discovery Program for Projected US$111 2B Global Metastatic Cancer Market - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
Propanc Biopharma Advances POP1 Joint Research and Drug Discovery Program for Projected US$111.2B Global Metastatic Cancer Market
MELBOURNE, Australia (BUSINESS WIRE)
Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Proenzymes Optimization Project 1 (“POP1”) joint research and drug discovery program advanced towards producing commercial scale quantities of the two proenzymes trypsinogen and chymotrypsinogen. The Company’s product candidate is targeting the global metastatic cancer treatment market, projected to be worth US$111.2 Billion by 2027, according to current analysis by Emergen Research.
AmeriCann Announces Record Revenue for 2020 albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
AmeriCann, Inc.: AmeriCann Announces Record Revenue for 2020
Company Reported Full Fiscal Year 2020 Financial Results
BOSTON, MA / ACCESSWIRE / December 22, 2020 / AmeriCann, Inc. (OTCQB:ACAN), a cannabis company that develops state-of-the-art cultivation, processing and product manufacturing facilities, announced its financial results for the 12 months ended September 30, 2020.
2020 Financial Highlights and Recent Developments
The Company achieved record revenue for its fiscal year ending September 2020.
AmeriCann s revenue increased by $796,520 from 2019 to 2020.
The Company s operating revenue increased in every quarter for its fiscal year ending September 2020.
AmeriCann s operating revenue from Building 1, the completed first phase of the Company s Massachusetts Cannabis Center ( MCC ), increased 178% for the quarter that ended September 30, 2020 from the prior quarter.